What the Tilray-Aphria Deal Means for Cannabis Investors

Here’s what to make of the upcoming Tilray (NASDAQ:TLRY) Aphria (TSX:APHA)(NASDAQ:APHA) merger.

| More on:
Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Boy, has 2021 been an interesting year for deal making. We’ve seen a tonne of deals proposed and a number of high-profile deals set to close.

Among these, there’s a big merger in the cannabis sector investors have their eye on right now. Let’s dive into the details for investors interested in what this deal could mean for the global cannabis industry.

Seismic shift about to take hold in the cannabis industry

The mega-merger that’s set to close between Canadian cannabis companies Aphria (TSX:APHA)(NASDAQ:APHA) and Tilray (NASDAQ:TLRY) will create the largest cannabis company in the world in terms of sales. This deal moved a step closer to approval recently when shareholders of both companies voted in favour of this deal.

The proposed new company would operate under the Tilray name, with Aphria investors owning 62% of the combined entity. Pooling their resources will give both the companies a better chance at succeeding in a relatively nascent industry. While there will be some managerial and operational hurdles near term, I think such a merger is crucial in the current economic turmoil.

Tilray shares are down 40% year to date, and Aphria is up 60%. So, the success of the new entity largely depends on how these businesses fuse. It is expected that this merged company will generate pre-tax annual cost synergies worth $100 million.

As global legalization efforts pick up, a company of this size will be hard to ignore. The new Tilray will have a portfolio of growing assets as well as numerous opportunities to expand Cannabis 2.0 products and increase margins over time. For investors buying cannabis companies on the basis of size and market share, the new Tilray is an intriguing choice today.

Risks do exist, so trade carefully

Of course, the combined entity will still have steep competition globally to contend with. The new Tilray will be a behemoth in the Canadian cannabis space. However, the U.S. market is the growth gem most investors are looking to right now.

Unfortunately for Aphria/Tilray investors, these companies are largely locked out of the U.S. THC market for the time being. Yes, some progress is being made in the U.S. CBD market. However, the combined entity will still likely lag its U.S. MSO peers for some time in terms of market share south of the border.

Indeed, it’s entirely possible the combined entity could make more headway in terms of U.S. expansion than investors anticipate. That’s a possibility. However, investors need to factor in some near-term risks with this stock related to international expansion.

Accordingly, I’m on the fence when it comes to Tilray and Aphria today. This company will be huge, for sure. But whether or not this stock is ultimately profitable over the next few years is the question mark I think will hamper these companies right now.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »